How analytics-driven insights can help drugmakers navigate the leap from trial to market—and add clinical and financial value at every step
Pharmaceutical Commerce - December 2020
A conversation with Jane Quigley, senior VP, Digital Health, PRA Health Sciences
Embracing AI 2.0 and modern machine learning as foundational tools to deepening HCP engagement
Using technology to enable processes, drive cost savings, and deliver better patient outcomes
Are regulations hindering pharma innovations?
Go-to safeguards for manufacturers in avoiding mismanagement of their business-central records
Building in the right processes and support for data quality, standards, and governance
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues
2
Pharma Pulse: CDC Layoffs Raise Public Health Concerns as Ypsomed and Lupin Expand US Manufacturing Footprint
3
Lupin Invests $250 Million in New Coral Springs Manufacturing Facility to Bolster US Respiratory Drug Supply
4
LogiPharma USA 2025: What Topics Do You Think Will headline the 25th LogiPharma USA?
5
